Company: LGN
Filing Date: 2025-11-03
Form Type: DRS
Source: 0001193125-25-262782
Chunk: 243

Company: Legence Corp.
Filing Date: 2025-11-03
Form: DRS
Chunk 243
---
---|:----|:----------|---:|
| Assets                                                                         |     |           |    |
| Current assets:                                                                |     |           |    |
| Cash                                                                           |     | $         | 10 |
| Total assets                                                                   |     |           | 10 |
| Liabilities and Stockholder’s Equity                                           |     |           |    |
| Liabilities                                                                    |     |           |    |
| Total liabilities                                                              |     |           |  — |
| Equity                                                                         |     |           |    |
| Common stock, $0.01 par value; 1,000 shares authorized, issued and outstanding |     |           | 10 |
| Total stockholder’s equity                                                     |     |           | 10 |
| Total liabilities and stockholder’s equity                                     |     | $         | 10 |

F-3

Confidential Treatment Requested by Legence Corp.

Pursuant to 17 C.F.R. Section 200.83

LEGENCE CORP.

NOTES TO BALANCE SHEET

1—Nature of Operations

Legence
Corp. was incorporated in the state of Delaware on January 9, 2025 in anticipation of a potential initial public offering (“IPO”) and related reorganization transactions. Following the IPO and the transactions related thereto,
Legence Corp. will be a holding company whose sole material asset will consist of membership interests in Legence Holdings LLC. After the consummation of the IPO and related reorganization transactions, Legence Corp. will be the managing member of
Legence Holdings LLC and will control and be responsible for all operational, management and administrative decisions relating to Legence Holdings LLC business and will consolidate the financial results of Legence Holdings LLC and its subsidiaries.

2—Summary of Significant Accounting Policies

Basis of Accounting and Presentation

The
accounts are maintained and the balance sheet has been prepared in accordance with accounting principles generally accepted in the United States of America. Separate statements of operations, changes in stockholders’ equity and cash flows have
not been presented because Legence Corp. has had no operations to date.

3—Stockholder’s Equity

Legence Corp. is authorized to issue 1,000 shares of common stock with a par value of $0.01 per share, all of which have been issued and are
outstanding as of March 27, 2025 for an aggregate consideration of $10.

4—Subsequent Events

Legence Corp. has evaluated subsequent events through April 29, 2025,